Covered recipient · General Payments record
JENNA R BRATCHER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,393.22
- Reported across 99 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $525.31 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $175.88 | 13 |
| Novo Nordisk AS | $162.02 | 12 |
| Corcept Therapeutics | $69.78 | 4 |
| PFIZER INC. | $68.00 | 4 |
| Medtronic, Inc. | $18.12 | 1 |
| Amgen Inc. | $18.04 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $13.47 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.97 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106817095 | CMS |
| ABBVIE INC. | $7.50 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106817097 | CMS |
| ABBVIE INC. | $13.92 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106817099 | CMS |
| ABBVIE INC. | $3.99 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106817101 | CMS |
| ABBVIE INC. | $14.02 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106817103 | CMS |
| ABBVIE INC. | $16.14 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106817105 | CMS |
| ABBVIE INC. | $11.16 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106817107 | CMS |
| ABBVIE INC. | $20.40 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106817109 | CMS |
| ABBVIE INC. | $18.30 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106817111 | CMS |
| ABBVIE INC. | $13.28 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106817113 | CMS |
| ABBVIE INC. | $14.23 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106817115 | CMS |
| ABBVIE INC. | $5.85 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106817117 | CMS |
| ABBVIE INC. | $18.12 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106817119 | CMS |
| Amgen Inc. | $18.04 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117512975 | CMS |
| Corcept Therapeutics | $14.55 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117790057 | CMS |
| Corcept Therapeutics | $18.80 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117790126 | CMS |
| Corcept Therapeutics | $15.43 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117790178 | CMS |
| Corcept Therapeutics | $21.00 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117790186 | CMS |
| Medtronic, Inc. | $18.12 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116971617 | CMS |
| Novo Nordisk Inc | $17.66 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100470290 | CMS |
| Novo Nordisk Inc | $6.95 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100599867 | CMS |
| Novo Nordisk Inc | $15.19 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100551340 | CMS |
| Novo Nordisk Inc | $17.34 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100334530 | CMS |
| Novo Nordisk Inc | $16.07 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100264640 | CMS |
| Novo Nordisk Inc | $13.76 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100258919 | CMS |
| Novo Nordisk Inc | $11.61 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100470378 | CMS |
| Novo Nordisk Inc | $11.92 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100226832 | CMS |
| Novo Nordisk Inc | $12.05 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100485857 | CMS |
| Novo Nordisk Inc | $11.54 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100499191 | CMS |
| Novo Nordisk Inc | $14.03 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100467818 | CMS |
| Novo Nordisk Inc | $13.90 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100341700 | CMS |
| PFIZER INC. | $21.35 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131809007 | CMS |
| PFIZER INC. | $15.16 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131797632 | CMS |
| PFIZER INC. | $13.64 | 08/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131877880 | CMS |
| PFIZER INC. | $17.85 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131044489 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $13.47 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153525919 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.